Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies

July 25, 2011 4:47 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Devices Industry Outlook Survey 2011–2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies...

Concentric Medical Launches DAC® 070, A New Distal Access Catheter

July 25, 2011 4:45 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., July 25, 2011 /- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC® 070 Catheter. The DAC 070 Catheter is the fourth and largest diameter...

The New Panasonic Toughbook CF-H2 Tablet Sets New Standards in Ease of Use, Connectivity and Productivity for Health Workers

July 25, 2011 4:45 am | by RealWire | News | Comments

Bracknell, UK. July 25, 2011 - Panasonic today launched the Toughbook CF-H2, its second generation, fully rugged tablet PC designed specifically for health workers. Setting new standards in ease of use, connectivity and productivity, the CF-H2 is a lightweight, water-resistant, shock and...

Advertisement

Genetic Testing Can Help the US Cut Costs and Improve Health Care

July 25, 2011 4:44 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, July 25, 2011 /PRNewswire-USNewswire/ -- Genetic testing made possible by the mapping of the human genome can help the US cut costs and create jobs while at the same time improving survival rates for such diseases as cancer, HIV, and heart disease. This according to Alan...

New Cancer Treatment Device Goes Into Service Today

July 25, 2011 1:40 am | by Bio-Medicine.Org | News | Comments

MANCHESTER, England, July 25, 2011 /-   - Experts Welcome Latest Advance as Promising Development for UK Patients A treatment system called the Novalis ® Tx™ has gone into service today, which has the ability to destroy cancerous cells virtually anywhere in the body in a...

Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada

July 25, 2011 1:40 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, July 25, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that its wholly owned subsidiary, Valeant Canada Limited, has received notice that the New Drug Submission for Sublinox has been approved from the Canadian regulatory...

Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

July 25, 2011 1:40 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017...

Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis

July 25, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, July 25, 2011 /- A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis (TB). Serological tests measure antibodies to TB in serum and are different to...

Advertisement

Free Delivery on All Health Care Products

July 24, 2011 12:42 pm | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, July 24, 2011 /PRNewswire-Asia/ -- Benefited by the convenience and health brought by series of health care products, more and more people are inclined to further purchase relative products for their friends as gifts, and for their families as an indispensable device to...

Index Shows Radiology Managers Still Have Low Confidence in Reimbursement Rates

July 23, 2011 1:33 pm | by Diagnostic Imaging | News | Comments

Medical imaging managers continue to have low confidence that reimbursement rates will improve in the near future and that funding for capital purchases will become readily available.

The Mechanics of Blast Injuries

July 22, 2011 1:39 pm | by Massachusetts Institute of Technology | News | Comments

Two studies mimic the effects of traumatic brain injury in cells, helping to explain how explosions harm soldiers' brains.

CVS Caremark Corporation to Hold Second Quarter 2011 Conference Call

July 22, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., July 22, 2011 /- CVS Caremark Corporation (NYSE: CVS ) will be holding a conference call on Thursday, August 4, 2011, at 8:30 a.m. (ET) with analysts and investors to discuss its second quarter 2011 financial results. (Logo:...

TPI Ships Macrolide API Samples for International Sales Standard Testing

July 22, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

CHENGDU, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in the research, development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded...

Advertisement

United Seating & Mobility Reaches Agreement to Acquire Central Kentucky Mobility

July 22, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, July 22, 2011 /- United Seating & Mobility (USM) is excited to announce today that it has finalized a transaction with Central Kentucky Mobility (CKM) to acquire and merge its complex mobility business with USM. USM/CKM will continue services for Lexington, Louisville, as...

Children's Hospital, Genethon get FDA OK for gene therapy trial

July 22, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Children's Hospital Boston has won approval from the U.S. Food and Drug Administration for a gene therapy trial in conjunction with French biotech Genethon to treat the rare immunodeficiency known as Wiskott-Aldrich syndrome.

Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories

July 22, 2011 7:44 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 22, 2011 /- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that...

Merz Pharmaceuticals Commends The Benign Essential Blepharospasm Research Foundation On 30 Years Of Community Support

July 22, 2011 7:40 am | by Bio-Medicine.Org | News | Comments

GREENSBORO, N.C., July 22, 2011 /- Merz Pharmaceuticals, LLC, commends the Benign Essential Blepharospasm Research Foundation (BEBRF) for 30 years of dedication to increasing awareness of blepharospasm, a neurological disorder that causes abnormal, involuntary spasms of the muscles around...

Elekta European Users' Conference Attracts Top Minds in Cancer Management

July 22, 2011 7:40 am | by Bio-Medicine.Org | News | Comments

STOCKHOLM, July 22, 2011 /- Elekta users from Europe, Asia, the Middle East, North America and Africa converged on Hotel Hohe Dune in Warnemunde, Germany June 16-19 to participate in Elekta's fifth European Users' Conference. Approximately 390 clinicians and scientists attended 31...

Dynatronics Appoints Bryan D. Alsop Vice President of Information Technology

July 22, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, July 22, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced the appointment of Bryan D. Alsop as its new vice president of information technology. "We are pleased to add Bryan to our management team," said Kelvyn Cullimore Jr., chairman and president of...

Ortho Clinical Diagnostics Launches VITROS 4600® Chemistry System for Mid- to High-Volume Laboratories

July 22, 2011 4:39 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 22, 2011 /- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that...

FDA Clears Siemens Software for Cerebral Blood Flow Assessment

July 22, 2011 4:35 am | by Diagnostic Imaging | News | Comments

Siemens Healthcare has received FDA 501(k) marketing clearance for a software package that helps in the assessment of cerebral blood flow during interventional procedures.

CT Bests Barium in Adult Celiac Disease Diagnosis

July 22, 2011 4:34 am | by Diagnostic Imaging | News | Comments

Improvements in computed tomography (CT) resolution of the small bowel, colon, and mesenteric lymph nodes have pushed CT scans ahead of traditional barium examinations in the diagnosis of celiac disease, according to a new study in the journal RadioGraphics.

Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102

July 22, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

TOKYO, July 22, 2011 /- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Toru Usami) announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at...

3SBio Inc. Schedules Unaudited Second Quarter 2011 Results

July 22, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

SHENYANG, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release...

£20k Raised For Yorkshire Hospices - Search Laboratory's Lycra Lads' Cycle To The Finish Line

July 21, 2011 11:39 pm | by RealWire | News | Comments

With the original target of £10,000 smashed a week before the Coast-to-Coast bike ride was due to take place, the team decided to raise their target and now have almost £20,000 to split between the two deserving charities; St Gemma's Hospice, Leeds and St Leonard's Hospice,...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading